AzTrials
AzTrials

HemiplegiaNCT04894097

Effect of Magnetic Therapy on Sonographic Findings , Pain and Function

A study testing magnetic therapy in people with Hemiplegia, run by Delta University for Science and Technology at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the current study will be focused on the following issues. Evaluation of the effect of magnetic therapy on sonographic findings ,the pressure pain threshold and disability in stroke hemiplegic shoulder. Read more about this study

Who is it for?
Ages 30 to 60 years
Conditions the study is for
Hemiplegia
What is being tested?
magnetic therapy
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteEgypt
Study dates
1 Aug 2025to 18 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patient's age was between 40 to 50 years old with
  • mild spasticity (grade 1, +1) according to modified Ashworth scale (MAS)
  • All conducted patients experienced a single stroke more than six months with cognitive capacity that enables them to comprehend and follow the instructions (Mini-Mental Scale score > 24).

Who cannot join

  • history of shoulder pain, trauma, or surgery before the stroke; current treatment with warfarin and an international normalized ratio greater than 4.0; use of oral non steroidal anti inflammatory drugs within 3 days before enrolment; or intra articular injections within the previous month. Patients who were unable to report their pain intensity, those with a cardiac pacemaker, and those with clinically significant osteoporosis were also excluded

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo university

    Cairo

Other trials in Egypt

About this study

Official title: Effect of Magnetic Therapy on Sonographic Findings , Pain and Function in Hemiplegic Shoulder Pain Patients

The purpose of the current study will be focused on the following issues. Evaluation of the effect of magnetic therapy on sonographic findings ,the pressure pain threshold and disability in stroke hemiplegic shoulder.

Read the detailed description

Further understanding of rotator cuff tendon impairment and other shoulder soft tissue structural abnormalities in stroke patients may help clinicians in assigning more complete therapeutic plans to hemiplegic patients. The radial extra-corporeal shock-wave therapy has promising results in patients with musculoskeletal problems and in those with various causes of HSP, including spasticity, rotator cuff problems, adhesive capsulitis, and complex regional pain syndrome.

Conditions
Hemiplegia
Being tested
magnetic therapy
Keywords
pain thrshold, ROM
Medical subject headings
Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • magnetic therapyDevice

    High intensity low frequency magnetic therapy

Study groups in NCT04894097
Study groupRoleWhat they receive
study groupActive comparatorPatients will received low frequency high intensity magnetic therapy
Receives: Device: magnetic therapy
control groupSham comparatorThe patients in this group will be treated by sham magnetic therapy
Receives: Device: magnetic therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sonographic findings

    Shoulder structural changes on the hemiplegic side were evaluated using a Samsung HS70A ultrasonography system (Samsung Medison, Seoul, Korea). Examinations were performed with the patient seated on a chair, and the affected shoulder was systematically scanned. The protocol included assessment of four major tendons long head of the biceps brachii, supraspinatus, infraspinatus, and subscapularis-as well as the glenohumeral joint and the presence of adhesive capsulitis, the latter determined by measuring coracohumeral ligament thickness.

    Ultrasound (USS) abnormalities were defined as follows. (a) A full-thickness rotator cuff tear was diagnosed when a full-thickness hypoechoic defect was observed, hyaline cartilage was visible, or there was a heterogeneous hypoechoic appearance of the cuff due to deltoid or subacromial-subdeltoid bursal herniation into the tendon. (b) A partial-thickness tear was identified as a hypoechoic defect within the tendon greater than 3 mm, or along the articul

    Measured: Baseline

Secondary outcomes (1)
  1. Shoulder range of motion assessment by using magnetic inclinometer

    Total shoulder flexion will be measured with full elbow extension and leading with the thumb to ensure consistent rotation. The inclinometer will placed along the shaft of the humerus perpendicular to the plane of motion. Total shoulder abduction will be measured with full elbow extension and leading with the thumb to ensure consistent rotation. The inclinometer will placed along the shaft of the humerus perpendicular to the plane of motion.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2021
  2. Study start1 Aug 2025
  3. Primary completion1 Jun 2026
  4. Study completion18 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
* The selected patients will be randomly assigned to two equal groups (study group (GI), and control group (GII). * The study group (GI) will be treated by magnetic therapy in addition to design physical therapy program. * The control group (GII) will be treated by sham magnetic therapy in addition to the same design physical therapy program of (GI).
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04894097
Sponsor's protocol ID
Cairo University
Status last verified
Jun 2026
First submitted
16 May 2021
Last updated
24 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wilson RD, Chae J. Hemiplegic Shoulder Pain. Phys Med Rehabil Clin N Am. 2015 Nov;26(4):641-55. doi: 10.1016/j.pmr.2015.06.007. Epub 2015 Sep 9.

    PubMed 26522903

Questions about this trial

What is this clinical trial studying?

A study testing magnetic therapy in people with Hemiplegia, run by Delta University for Science and Technology at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sonographic findings (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04894097, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in